The human papillomavirus (HPV) vaccine reduces the prevalence of genital warts and the
cancers they are associated with in males. However, the vaccination of males has always …

Objectives: To investigate the acceptability of human papillomavirus (HPV) vaccination
among men who have sex with men (MSM) and its associated factors. Methods: We …

Background Targeted human papillomavirus (HPV) vaccine could prevent HPV-related
cancers and genital warts among men who have sex with men (MSM). In order to develop …

Objectives If approved for use in young males in the United States, prophylactic human
papillomavirus (HPV) vaccine may reduce the incidence of HPV-related disease in …

Background: For human papillomavirus (HPV) vaccination to have maximum benefit to
public health, both men and women should be vaccinated. Although efficacy trials in men …

Objective To understand rates of human papillomavirus (HPV) vaccine acceptability and
factors correlated with HPV vaccine acceptability. Design Meta-analyses of cross-sectional …

ABSTRACT HPV is associated with malignancy in men, yet there is a lack of data on HPV
knowledge, vaccine acceptability, and factors affecting vaccine acceptability in Greek men …

Our aim was to gain a better understanding of the knowledge about Human Papillomavirus
(HPV) infection and attitudes toward the HPV vaccine among men at risk for sexually …

Background: Human papillomavirus (HPV) infection is the most common sexually
transmitted disease, and it is associated with anogenital warts and oropharyngeal and …

Human papillomavirus (HPV) can cause various diseases; low-risk strains can cause genital
warts, whereas high-risk strains can cause cervical cancer and cancer of the vulva in women …